1. no IND's filed 2. no products close to trials 3. unresolved intellecual propery issues 4. no revenue 5. continued dilution 6. declining share price 7. no deadlines met 8. no promises kept 9. unresolved lawsuits 10. management continuing to reward themselves with shares for doing a great job.